-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?
Rapid Communication
(2145) Views (657) Full article downloads
Authors: Sergio Parco
Published Date May 2010
Volume 2010:3 Pages 113 - 116
DOI: http://dx.doi.org/10.2147/DMSO.S8504
Sergio Parco
Immunopathology Unit, Laboratory of the Department of Medicine, Children’s Hospital, IRCCS Burlo Garofolo, Trieste, Italy
Abstract: Recent observations suggest the presence of an interaction between leptin and the inflammatory system during bronchial asthma. Although there is evidence of a positive association between asthma and obesity in adults and children, little is yet known about the role of serum leptin, as a potential mediator for bronchial epithelial homeostasis, and intraleukocyte myeloperoxidase (MPO), a hemoprotein with a molecular weight of 140 kDa, expression of the inflammatory system, in asthmatic children. Glycemic tolerance is an important pathogenetic element in developing type 2 mellitus diabetes and a confirmed predictor of incident asthma-like symptoms in adults. This work is aimed at assessing a possible correlation between basal leukocyte myeloperoxidase levels, basal leptin and insulin-glycemic tolerance in obese children. Thirty obese children aged between 7 and 15 years were examined. The analyzed data showed a normal response to the insulinemic stimulus in children of both sexes whose basal leptin and MPO values, expressed as MPO intracellular index, werewithin the normal range.
Keywords: leptin, myeloperoxidase, glycemic tolerance, asthma
Other articles by Dr Sergio Parco
Celiac disease and immigration in Northeastern Italy: the “drawn double nostalgia” of “cozonac” and “panettone” slices
Management of immigration and pregnancy screening in northeastern Italy
Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
Readers of this article also read:
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Risk management in the treatment of type 2 diabetes with pioglitazone
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
Tackling obesity: new therapeutic agents for assisted weight loss
New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- The economic impact of obesity in the United States
- Alogliptin: a new addition to the class of DPP-4 inhibitors
- Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
- Adipose inflammation: cause or consequence of obesity-related insulin resistance




